companydata.dkNovo Nordisk North America Operations A/S: Financial statements 2020
CVR: 33761201
Novo Nordisk North America Operations A/S (CVR 33761201) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK 34,830,000 compared with DKK 189,945,000 the year before. Equity amounted to DKK 9,214,437,000. The solvency ratio was 84%.
- Profit/Loss
- 34,830,000 kr.
- Equity
- 9,214,437,000 kr.
- Total Assets
- 10,963,882,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | - | 34.8 mio. | 9.2 mia. | - |
| 2019 | - | - | 189.9 mio. | 728.5 mio. | - |
| 2018 | - | - | 730 t. | 3.4 mio. | - |
| 2017 | - | - | -2.4 mio. | 2.7 mio. | - |
| 2016 | - | - | -5.3 mio. | 25.1 mio. | - |
How creditworthy is Novo Nordisk North America Operations A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 15, 2020, Linette Tangsgaard Nielsen has joined the board of directors of Novo Nordisk North America Operations A/S.
As of December 15, 2020, Lene Moth Bang has left the board of directors of Novo Nordisk North America Operations A/S.
Novo Nordisk North America Operations A/S has published its annual report for 2019. The net result was DKK 189,945,000.
About Novo Nordisk North America Operations A/S
Novo Nordisk North America Operations A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2011. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named Novo Nordisk Invest 3 A/S and NOVO NORDISK REGION NORTH AMERICA II A/S. The management consists of Anders Rytter Mikkelsen. The company is owned by NOVO NORDISK A/S. In 2025, the company reported a gross profit of DKK -59,000 and a net result of DKK -74,142,000 compared with DKK -89,167,000 the year before. Equity amounted to DKK 60,045,000.